tiprankstipranks
Trending News
More News >
Merit Medical (MMSI)
NASDAQ:MMSI
US Market

Merit Medical Systems (MMSI) Ratios

Compare
350 Followers

Merit Medical Systems Ratios

MMSI's free cash flow for Q4 2025 was $0.50. For the 2025 fiscal year, MMSI's free cash flow was decreased by $ and operating cash flow was $0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
4.34 4.34 4.27 5.45 2.40
Quick Ratio
2.95 2.95 2.85 3.95 1.19
Cash Ratio
1.87 1.87 1.74 2.88 0.26
Solvency Ratio
0.24 0.24 0.23 0.17 0.32
Operating Cash Flow Ratio
1.24 1.24 1.02 0.71 0.52
Short-Term Operating Cash Flow Coverage
27.34 27.34 0.00 0.00 5.14
Net Current Asset Value
$ -61.47M$ -61.47M$ -115.47M$ -14.77M$ 9.52M
Leverage Ratios
Debt-to-Assets Ratio
0.33 0.33 0.33 0.38 0.17
Debt-to-Equity Ratio
0.57 0.57 0.58 0.74 0.24
Debt-to-Capital Ratio
0.36 0.36 0.37 0.43 0.20
Long-Term Debt-to-Capital Ratio
0.34 0.34 0.35 0.41 0.14
Financial Leverage Ratio
1.70 1.70 1.75 1.93 1.45
Debt Service Coverage Ratio
7.76 7.76 7.83 13.62 6.05
Interest Coverage Ratio
6.98 6.98 4.99 7.99 13.81
Debt to Market Cap
0.20 0.16 0.13 0.19 0.05
Interest Debt Per Share
15.58 15.63 14.19 15.75 5.04
Net Debt to EBITDA
1.35 1.35 1.53 1.33 1.22
Profitability Margins
Gross Profit Margin
48.70%48.70%47.43%46.44%45.10%
EBIT Margin
13.02%13.02%11.74%10.15%7.73%
EBITDA Margin
21.90%21.90%20.20%18.20%15.74%
Operating Profit Margin
12.19%12.19%11.48%9.86%7.61%
Pretax Profit Margin
11.28%11.28%11.06%8.91%7.18%
Net Profit Margin
8.48%8.48%8.87%7.51%6.47%
Continuous Operations Profit Margin
8.48%8.48%8.87%7.51%6.47%
Net Income Per EBT
75.17%75.17%80.24%84.23%90.18%
EBT Per EBIT
92.54%92.54%96.34%90.44%94.37%
Return on Assets (ROA)
4.78%4.78%4.98%4.06%4.48%
Return on Equity (ROE)
8.52%8.11%8.73%7.85%6.51%
Return on Capital Employed (ROCE)
7.55%7.55%7.07%5.84%6.07%
Return on Invested Capital (ROIC)
5.65%5.65%5.65%4.89%5.35%
Return on Tangible Assets
7.83%7.83%8.26%5.84%7.25%
Earnings Yield
3.21%2.46%2.14%2.16%1.86%
Efficiency Ratios
Receivables Turnover
6.78 6.78 6.49 6.64 6.45
Payables Turnover
12.84 12.84 10.41 10.21 9.22
Inventory Turnover
2.33 2.33 2.33 2.22 2.38
Fixed Asset Turnover
2.94 2.94 3.00 2.82 2.57
Asset Turnover
0.56 0.56 0.56 0.54 0.69
Working Capital Turnover Ratio
1.95 2.01 1.68 2.07 4.15
Cash Conversion Cycle
182.05 182.05 177.86 183.88 170.67
Days of Sales Outstanding
53.84 53.84 56.28 54.94 56.59
Days of Inventory Outstanding
156.63 156.63 156.64 164.68 153.65
Days of Payables Outstanding
28.42 28.42 35.06 35.74 39.57
Operating Cycle
210.47 210.47 212.92 219.62 210.24
Cash Flow Ratios
Operating Cash Flow Per Share
5.01 5.03 3.79 2.52 2.01
Free Cash Flow Per Share
4.25 3.65 3.14 1.88 1.22
CapEx Per Share
0.76 1.38 0.65 0.64 0.79
Free Cash Flow to Operating Cash Flow
0.85 0.73 0.83 0.75 0.61
Dividend Paid and CapEx Coverage Ratio
6.61 3.64 5.80 3.95 2.54
Capital Expenditure Coverage Ratio
6.61 3.64 5.80 3.95 2.54
Operating Cash Flow Coverage Ratio
0.33 0.33 0.28 0.16 0.41
Operating Cash Flow to Sales Ratio
0.20 0.20 0.16 0.12 0.10
Free Cash Flow Yield
6.29%4.14%3.25%2.48%1.73%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
31.56 40.58 46.78 46.34 53.84
Price-to-Sales (P/S) Ratio
2.68 3.44 4.15 3.48 3.49
Price-to-Book (P/B) Ratio
2.56 3.29 4.08 3.64 3.51
Price-to-Free Cash Flow (P/FCF) Ratio
16.09 24.18 30.81 40.34 57.92
Price-to-Operating Cash Flow Ratio
13.64 17.53 25.50 30.14 35.10
Price-to-Earnings Growth (PEG) Ratio
3.96 8.40 1.78 1.84 1.03
Price-to-Fair Value
2.56 3.29 4.08 3.64 3.51
Enterprise Value Multiple
13.58 17.06 22.08 20.44 23.37
Enterprise Value
4.46B 5.66B 6.05B 4.68B 4.23B
EV to EBITDA
13.43 17.06 22.08 20.44 23.37
EV to Sales
2.94 3.74 4.46 3.72 3.68
EV to Free Cash Flow
17.67 26.26 33.10 43.15 61.12
EV to Operating Cash Flow
15.00 19.05 27.40 32.24 37.04
Tangible Book Value Per Share
9.10 9.12 7.17 8.58 8.96
Shareholders’ Equity Per Share
26.70 26.78 23.69 20.87 20.15
Tax and Other Ratios
Effective Tax Rate
0.25 0.25 0.20 0.16 0.10
Revenue Per Share
25.54 25.62 23.30 21.83 20.26
Net Income Per Share
2.17 2.17 2.07 1.64 1.31
Tax Burden
0.75 0.75 0.80 0.84 0.90
Interest Burden
0.87 0.87 0.94 0.88 0.93
Research & Development to Revenue
0.06 0.06 0.06 0.07 0.07
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.03 0.03 0.02 0.02 0.02
Income Quality
2.31 2.31 1.83 1.54 1.53
Currency in USD